Custom sequencing panels optimized for targeted analysis of specific genomic content of interest. Enables focused genomic investigation for specialized research applications.
Manufactured by
Illumina
United States
Illumina is a leading provider of next-generation sequencing (NGS) and array technologies that enable genomic discovery and precision diagnostics across research, clinical, and consumer applications. The company manufactures a comprehensive portfolio of sequencing instruments ranging from benchtop to production-scale platforms, coupled with advanced chemistry and software solutions for genome analysis, methylome profiling, and spatial sequencing. Illumina's integrated genomic solutions serve researchers and clinicians in life sciences, molecular diagnostics, and translational medicine, supporting drug discovery, disease detection, and personalized health applications. The company combines innovative hardware, consumables, and bioinformatics tools to accelerate genomic insights and clinical outcomes.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Molecular Designs
United States · 3 relevant products
Nonacus
United Kingdom · 11 relevant products
HOLOGIC
China · 1 relevant product
23 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 46 closest product alternatives
Molecular Designs · United States
Portfolio of eight distinct research assay panels with customizable configurations designed to run on most PCR platforms. Panels are engineered to identify low-abundance targets and support cost-effective molecular research.
Nonacus · United Kingdom
Custom NGS panels for targeted resequencing using Cell3 Target technology to convert cell-free DNA (cfDNA), genomic DNA (gDNA), and formalin-fixed paraffin-embedded (FFPE) DNA into libraries for next-generation sequencing. The panels are validated for ctDNA, gDNA, and FFPE DNA samples for oncology applications including early cancer detection and cancer monitoring. They incorporate error suppression technology with unique molecular indexes (UMIs) and unique dual indexes (UDIs) to enable confident variant calling down to 0.1% VAF, with support for as little as 1 ng of genomic or cfDNA input and 10 ng of FFPE material.
Nonacus · United Kingdom
Targeted sequencing panels designed for longitudinal patient monitoring and treatment response assessment. Enables detection of minimal residual disease and tracking of genomic changes over time to inform ongoing clinical management.
43 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products